Fenofibrate/simvastatin, sold under the brand name Cholib, is a fixed-dose combination medication used to treat abnormal blood lipid levels when used in combination with a low-fat diet and exercise. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. It contains fenofibrate and simvastatin.
It was approved for use in the European Union in August 2013.
Medical uses Fenofibrate/simvastatin is indicated as adjunctive therapy to diet and exercise in high cardiovascular risk adults with mixed dyslipidemia to reduce triglycerides and increase HDL C levels when LDL C levels are adequately controlled with the corresponding dose of simvastatin monotherapy.
Adverse effects
References
Further reading